Colloidal super-paramagnetic microbeads conjugated with annexin V are effective for separating apoptotic spermatozoa by MACS as a result of the high affinity of annexin V for externalized PS molecules. The effectiveness of the procedure in reducing the percentage of sperm with fragmented DNA and abnormal morphology has also been reported. However, it is still unknown if it could decrease the percentage of aneuploid spermatozoa. The objective of our prospective study, performed on 16 males with abnormal FISH on spermatozoa, was to assess if MACS columns were useful tools to retain spermatozoa carrying chromosomal abnormalities in semen samples processed after density gradient centrifugation (DGC). The pellet obtained after DGC was subjected to MACS, and sperm FISH analyses were performed both in the eluded fraction and in the fraction retained in the column. The observed frequencies of disomy and nullisomy 13, 18, and 21, X and Y, as well as the diploidy rates in the MACS eluded fraction and the fraction retained in the MACS column were recorded. We observed that the frequencies of aneuploidies in the eluded fraction were lower than in the fraction retained in the MACS column (0.59% vs. 0.75%; p = 0.010). DGC determined a significant reduction in sperm concentration (z-ratio = 2.83; p = 0.005) and a significant increase in sperm progressive motility (z-ratio = À3.5; p < 0.001). MACS also led to a significant reduction in sperm concentration (z-ratio = 3.14; p = 0.002) and a significant increase in progressive motility (z-ratio = À2.59; p = 0.01) when compared with the post-DGC sample. Sperm concentration was similar in the two fractions generated by MACS (z-ratio = 0.63; p = 0.52), while progressive motility was significantly higher in the MACS eluded fraction (z-ratio = 2.42; p = 0.02). According to our results, MACS columns are able to selectively retain spermatozoa carrying chromosomal abnormalities. Furthermore, the performance of DGC and MACS on semen samples leads to an enrichment of progressive motility.
INTRODUCTION
Cell sorting is a process that consists of selecting cells based on characteristics such as size, morphology or membrane markers. This resource has become an important tool in cell biology, immunology, stem cell research and cancer research, allowing for the obtainment, culture and analysis of defined cell populations (Dainiak et al., 2007) . In 1977, Molday et al. reported that the magnetic separation of cells was possible using iron-containing polymeric microspheres tagged with fluorescent dyes and chemically coupled to antibodies or lectins (Molday et al., 1977) . This technique, combined with microscopy and flow cytometry, has been widely used in research as a method of cell identification and separation. More recently, the development of separation columns, containing magnetized matrices capable of retaining cells bound to iron microspheres (Miltenyi et al., 1990) , patented and marketed under the name of MACS â (Magnetic Activated Cell Sorting, Miltenyi Biotec GmbH, Bergisch Gladbach, Germany), has resulted in the implementation of the procedure as it allows unlabeled cells to pass through a magnetic column while labeled cells are retained. In 2001, it was shown that colloidal super-paramagnetic microbeads conjugated with annexin V were highly effective for separating apoptotic spermatozoa by MACS (Grunewald et al., 2001) . The procedure was based on the well-known phenomenon of phosphatidylserine (PS) externalization to the cell 0 s outer surface membrane that occurs during apoptosis. This universal phenomenon takes place independently of the species, cell type and mechanism of cell death induction. PS externalization begins when the execution phase is initiated, and it lasts until the final phase (van Engeland et al., 1998) , serving as a tag for specific recognition by macrophages and for phagocytosis of the dying cell (Fadok et al., 2000) . Furthermore, the high affinity of annexin V for externalized PS molecules was used to trap apoptotic cells with the microbeads. MACS advantages are its simplicity, fast performance, low cost and high specificity. MACS microbeads are biodegradable, do not affect cell viability (Miltenyi et al., 1990) , and no deleterious effects have been reported on the spermatozoa (Grunewald et al., 2009) . However, MACS can lead to significant cell loss (Cakar et al., 2016) and it increases the steps of centrifugation, as it has to be used in conjunction with density gradients centrifugation (DGC) or swim up (SU) to exclude seminal plasma, leukocytes and immature germ cells (Said et al., 2008) . Moreover, research is still needed to ensure the complete absence of freely floating microbeads in the non-apoptotic sperm fraction.
The effectiveness of the procedure in reducing the percentage of apoptotic spermatozoa in the processed samples (Said et al., 2006) , the percentage of sperm with fragmented DNA (Lee et al., 2010) and the percentage of sperm with abnormal morphology (Aziz et al., 2007) (Dirican et al., 2008) has been reported. Concerning sperm motility after MACS processing, discordant results have been published, with some authors indicating that it improves (Vant ery Arrighi et al., 2009), others reporting that it is reduced (Lee et al., 2010) (Grunewald et al., 2001) , and some studies indicating no differences (Said et al., 2006) (Aziz et al., 2007) (Degheidy et al., 2015 ) (Romany et al., 2014 .
Only a few studies have addressed the benefits of MACS on take-home baby rate, in comparison with standard sperm selection methods (Dirican et al., 2008) (Polak de Fried & Denaday, 2010 ) recent meta-analysis showed some improvement in pregnancy rate, although no differences were reported in implantation and miscarriage rates (Gil et al., 2013) .
FISH (Fluorescence in situ hybridization) technique was introduced in the nineties for the study of sperm chromosomes (Wyrobek et al., 1990) . Studies in controls have shown a total frequency of sperm aneuploidy around 6% (Egozcue et al., 1997) , with a frequency of disomy around 0.12% for each autosome pair and 0.27% for the sex chromosomes (Templado et al., 2011) . It has been observed that patients with a clinical background of recurrent miscarriages of unknown etiology or implantation failure after ICSI are at risk of being more prone to sperm chromosomal abnormalities, the incidence of which is higher in oligoasthenoteratozoospermic patients (Rubio et al., 2001) . Studies that compared the frequency of chromosomal abnormalities to the seminogram have found that sperm count (Sarrate et al., 2010) and progressive motility (Vegetti et al., 2000) were inversely correlated with the percentage of such anomalies. The clinical significance of sperm chromosomal abnormalities is clear: aneuploid sperm lead to aneuploid embryos, lower pregnancy and implantation rates, and increased miscarriage rate (Burrello et al., 2003) .
Apoptosis in male germ cells has to occur for the maintenance of an optimal ratio of germ cells/Sertoli cells, and also to remove germ cells that are damaged as a result of exposure to environmental toxicants, chemotherapeutic agents, or heat (Wang et al., 2007) . What is still unknown is if apoptosis could be triggered for the removal of spermatozoa carrying chromosome abnormalities, and which mechanisms might lead to such triggering. Some studies have assessed the possible connection between sperm aneuploidy and apoptosis and/or sperm DNA fragmentation with controversial results. Vendrell et al., (2014) reported that abnormal chromosomal segregation was not clearly related to early apoptosis and Garcia-Quevedo et al., (2014) , found that aneuploid testicular spermatozoa did not display a significant increase in PS externalization. However, other authors have reported an association between sperm aneuploidy and DNA fragmentation, concluding that it was likely that DNA-fragmented spermatozoa were apoptotic cells (Muriel et al., 2007) . Moreover, PS externalization and DNA fragmentation rates were reported to be significantly higher in ejaculated spermatozoa of chromosomal translocation carrier patients than in donor sperm (Brugnon et al., 2006) .
A recent study (Vendrell et al., 2014) analyzed a series of six normozoospermic patients with implantation failure and reported a reduction in the sperm aneuploidy rate in the eluded MACS fraction, when compared to the preprocessed samples. To our knowledge, this is the only study suggesting that the use of MACS columns could be useful for retaining chromosomally abnormal spermatozoa, although the investigators did not analyze the aneuploidy rate in the fraction retained in the column.
In this study, we evaluated if MACS columns were able to retain spermatozoa carrying chromosomal abnormalities. Furthermore, sperm parameters after MACS were compared to the fresh and post-DGC fraction, and the percentage of cell loss after the technique was calculated.
MATERIAL AND METHODS

Patients
The present Inclusion criteria were a normal karyotype and abnormal values on a previous sperm FISH analysis that was requested for a previous IVF failure. The only exclusion criterion was the presence of less than 5 9 10 6 /mL spermatozoa after DGC. This was established in order to secure a sufficient number of sperm cells for the performance of the MACS separation protocol.
Study design
A schematic representation of the study design is presented in Fig. 1 . In brief, one aliquot of the raw sperm sample was used to assess routine sperm parameters. The remaining sample was processed by density gradient centrifugation (DGC). Sperm parameters were determined once the procedure was concluded and the pellet obtained was subjected to MACS. Assessment of sperm parameters was performed in the eluded fraction and in the fraction retained in the column, and FISH analysis was performed in both fractions.
808 Andrology, 2017, 5, 807-813 Sperm collection and DGC Semen samples were collected by masturbation into non-toxic sterile plastic jars after 3-5 days of sexual abstinence. Samples were allowed to liquefy for 30 min at room temperature (22°C) and evaluated according to the WHO criteria (World Health Organization, Department of Reproductive Health and Research, 2010) . ALLGrad â (LifeGlobal â , Guelph, Canada) was diluted in medium for Global Fertilization â (LifeGlobal â ) to obtain dilutions of 45%, 70% and 90%. Two gradient columns were prepared in Falcon â tubes by gently layering 1 mL of each solution, starting from the 90% fraction at the bottom. One mL of the semen sample previously washed during 10 min at 350 g with Global Fertilization â was stratified on top of the discontinuous gradient columns and centrifuged for 18 min at 300 g. After centrifugation, the obtained pellet was collected and washed twice at 350 g for 5 min. After processing by DGC, a second evaluation of sperm parameters was carried out and the pellet was processed through MACS.
MACS
Following the manufacturer's instructions, the pellet was incubated in the dark at room temperature for 15 min with the provided annexin-V conjugated microbeads (Miltenyi Biotec S.L., Madrid, España). One hundred microliters of microbeads were used for every 10 million separated cells.
The separation column composed by a coated cell-friendly matrix containing iron balls was fitted in a magnet (Mini-MACS; MiltenyiBiotec S.L.). After rinsing the column with 0.5 mL of Global Fertilization â , the cell suspension was added and the eluded fraction was recovered. To obtain the retained fraction, the column was taken out of the magnet, 0.2 mL of medium was added to the column and the eluded material was recovered.
Sperm parameters assessment and sperm FISH analyses were performed on both eluded and retained fractions of each patient.
FISH in decondensed sperm nuclei
Sperm samples were fixed in Carnoy's solution (methanol/ acetic acid, 3 : 1; Merck, Madrid, Spain). In average, 1017 sperm cells in the eluded fraction and 1020 in the column fraction were scored for every single patient and probe. FISH procedures were performed by one expert as previously described (Sarrate & Anton, 2009) , and observed anomalies were contrasted with the supervisor of the FISH experiments.
The analysis was addressed to the evaluation of chromosomes 13, 18, 21, X and Y by using the panel AneuVysion DNA Multicolor Probe Kit (Abbott Molecular Inc., Des Plaines, IL, USA).
The preparations were evaluated under an Olympus BX60 epifluorescence microscope (Olympus, Barcelona, Spain) equipped with a triple-band filter for 6-diamino-2-phenylindole (DAPI)/ Texas Red/fluorescein isothiocyanate conjugate (FITC) and single-band filters for FITC, Texas Red, and Aqua. Signal scoring was performed according to the strict analysis criteria described previously (Blanco et al., 1996) .
The observed frequencies of disomy and nullisomy for the sex chromosomes and for chromosomes 13, 18, and 21, as well as the diploidy rates were recorded.
Statistical analysis
Data were analyzed using IBM SPSS Statistics for WINDOWS, version 19 (IBM Corp., Armonk, NY, USA). For statistical analyses, a non-parametric two-tailed Wilcoxon Matched Pairs test was used to compare sperm concentration and progressive motility between raw and post-DGC sperm samples, between post-DGC sperm sample and the MACS eluded fraction, and between the two sperm fractions generated by MACS. The Chi-square test was used to compare differences in frequencies of numerical chromosomal abnormalities detected by FISH in the two sperm fractions generated by MACS. Statistical significance was defined as p < 0.05. Difference between the frequency of numerical chromosomal abnormalities in the two MACS generated fractions was the outcome considered for the calculation of sample size. A significance level of 0.05 and a power of 0.8 were defined. Based on previously published data, the expected effect size was 0.3 and the underlying event rate for the chromosomal abnormalities assessed was 0.015. Taking these parameters into account, the sample size for each arm of the study was around 13,000 spermatozoa.
RESULTS
The ages of the 16 individuals ranged from 33 to 47 years (mean age AE standard deviation = 39 AE 4). Their female partners were aged 33 to 46 years (38 AE 3) and duration of infertility ranged from 1 to 4 years (2.4 AE 1). Concerning the indications for ART, 12 of the 16 couples had more than one specified. In three cases, three indications were present. Their frequencies were distributed as follows: nine cases of male factor, seven cases of ovarian factor, five cases of advanced maternal age, three cases of prevention of genetic disease, two cases of endometriosis, two cases of tubal factor, two cases of repeated miscarriage and one case of polycystic ovarian syndrome.
In total, 65,298 sperm were analyzed by FISH, and 804 (1.23%) were abnormal for the chromosomes studied. Differences in the frequencies of aneuploid and diploidy between the MACS eluded fraction and the fraction retained in the MACS column are shown in Table 1 . Data from all individuals were grouped by the type of numerical chromosomal abnormality. In all of the 17 comparisons made, with the single exception of nullisomy 18 (where figures were the same), the frequency of numerical chromosomal abnormalities was higher in the retained fraction. A statistically significant decrease in total aneuploidy (0.59% vs. 0.75%, p = 0.01) and in the rate of total chromosomal abnormalities (aneuploidy + diploidy) (1.1% vs. 1.37%, p = 0.002) was detected in the eluded fraction when compared to the retained fraction. The same was observed for chromosome 21 aneuploidy (0.24% vs. 0.36%, p = 0.047). Table 2 summarizes data on sperm parameters for each individual in four samples: raw, post-DGC, the MACS eluded fraction and the fraction retained in the MACS column. As expected, DGC determined a significant reduction in sperm concentration (z-ratio = 2.83; p = 0.005) and a significant increase in sperm progressive motility (z-ratio = À3.5; p < 0.001). Likewise, MACS also led to a significant reduction in sperm concentration (z-ratio = 3.14; p = 0.002) and a significant increase in progressive motility (z-ratio = À2.59; p = 0.01) when compared to the post-DGC sample. Sperm concentration was similar in the two fractions generated by MACS (z-ratio = 0.63; p = 0.52), while progressive motility was significantly higher in the MACS eluded fraction (z-ratio = 2.42; p = 0.02).
The average number of spermatozoa lost after MACS was an additional 54.0% compared with samples after DGC.
DISCUSSION
In this study we observed a positive correlation between sperm aneuploidy and MACS retention: a higher percentage of disomy and aneuploidy were observed in the retained fraction, and statistical significance was reached when total aneuploidies and chromosomal abnormalities (total aneuploidy + diploidy) were analyzed. To the best of our knowledge, our study is the first to compare the percentages of sperm carrying chromosomal abnormalities in the eluded fraction vs. the retained fraction. Our results are consistent with those from previous studies reporting an association between aneuploidy and apoptosis (Perrin et al., 2011) , as well as with the study reporting that processing samples through MACS decreases sperm aneuploidy rates (Vendrell et al., 2014) .
MACS for sperm selection is being used in ART in addition to the classical sperm preparation techniques (DGC, SU). However, more information about MACS is still needed. The technique has been used in the research field for many years, but there is still little data concerning the clinical effects and outcomes obtained after its use (Gil et al., 2013) and there is no consensus on the preparation sequence (MACS pre-or post-DGC/SU) (Tavalaee et al., 2012) (Bucar et al., 2014) . Furthermore, although some sperm characteristics have been shown to improve after MACS, such as the rate of apoptosis (Said et al., 2006) , DNA fragmentation (Lee et al., 2010) and morphology (Aziz et al., 2007) (Dirican et al., 2008) , others like the percentage of chromosomally abnormal sperm are still under investigation.
It has been proposed that an abnormal chromosomal content in the spermatozoon nucleus might disturb its fine three-dimensional architecture, leading to a higher sensitivity to exogenous factors of apoptosis (Rouen et al., 2013) . Based on this hypothesis, the goal of the present study was to determine if spermatozoa carrying numerical chromosomal abnormalities tended to be retained in the MACS columns, as a result of the hypothetical increase in PS externalization.
A recent publication compared the percentage of diploidy, nulisomy, and disomy for chromosomes 18, X and Y on spermatozoa from a pool of samples obtained from 6 patients before and after MACS (Vendrell et al., 2014) . The authors 810 Andrology, 2017, 5, 807-813 reported a decrease in the nulisomy and aneuploidy rates for chromosome 18, and a decrease in the total aneuploidy rate after processing through MACS. Our study design differs considerably from the previous one, as we have analyzed the eluded and the retained sperm fractions in each individual separately, with the aim of assessing the tendency of chromosomally abnormal spermatozoa to be retained in the MACS columns.
An initial high percentage of aneuploid spermatozoa seemed adequate to make the putative MACS effect easier to document. Therefore, patients included in the study had an abnormal previous sperm FISH report. In the study design of the present paper, FISH was not performed before and after DGC because the priority of our study was to have enough sperm cells to investigate if MACS columns could retain chromosomally abnormal sperm. Previous unpublished data from our center evidenced that our sperm recuperation ratio after DGC is low, although it gives samples with a high percentage of progressive motility. The low recuperation ratio could be related to our sperm preparation protocol, which includes short centrifugations at low g and three layers of gradients of 1 mL each. Focusing on the eluded and retained fraction after MACS, we obtained a high number of spermatozoa for FISH analysis (32,578 from the eluded fraction and 32,720 from the retained fraction) although only 16 individuals were recruited.
One of the early features of spermatozoa that initiate the apoptotic cascade is a rapid loss of motility (De Iuliis et al., 2009) , and it has been demonstrated that DGC and MACS can reduce the percentage of cells that display apoptotic markers (Said et al., 2006) . In our study, DGC led to a significant increase in mean progressive motility (from 33.8% to 80.0%), and a further improvement was seen after the MACS columns were applied (from 80.0% to 85.8%). Similar progressive motility improvement after MACS was previously reported (from 69.3% to 75.6%) (Vant ery Arrighi et al., 2009), though others described a decrease in this parameter (from 28.9% to 26.1%) (Lee et al., 2010) . These discrepancies may reflect differences in specific aspects of the protocols followed.
Different preparation protocols, etiologies of infertility and initial quality of sperm samples could also explain why in this study the average number of cells after MACS decreased by 54.0% compared to the post-DGC fraction, while other authors observed reductions of 15.0% (Said et al., 2006) and 24.0% (Vant ery Arrighi et al., 2009 ).
In conclusion, according to our data, aneuploid sperm cells are preferentially retained in the MACS column, which indicates that PS externalization tends to occur more frequently in these cells. Taking into consideration the percentages of chromosomally abnormal spermatozoa seen in the retained and the eluded MACS fractions, the clinical impact of the use of this technique in the prevention of embryo chromosomal abnormalities will need to be defined in future studies. Vol. = volume (mL); Conc. = concentration(10 6 /mL); PM = % of progressive motility. *Concentration significantly reduced from raw to post-DGS sample and from post-DGS sample to the MACS eluded fraction. No significant difference between the MACS eluded fraction and the fraction retained in column. **Progressive motility significantly increased from raw to post-DGS sample and from post-DGS sample to MACS eluded fraction. Significantly higher progressive in the MACS eluded fraction in comparison with the fraction retained in column.
